Refludan anvendes til antikoagulation (hæmning af blodpropdannelse) hos voksne patienter med heparin- induceret trombocytopeni (blodplademangel) type II HIT samt tromboembolisk sygdom (blodpropper), som kræver injiceret antithrombotisk medicin.
Refludan is used for anticoagulation in adult patients with heparin-induced thrombocytopenia (HIT) type II and thromboembolic disease requiring injected antithrombotic medicines.